Keith Publications Logo Keith Publications
  Cluster 3: Health, Medicine & Life Sciences

Journals for International Clinical Trials (2026)

International clinical trials — conducted simultaneously across multiple countries to evaluate treatments in diverse patient populations — generate the highest level of clinical evidence but also present unique methodological, ethical, and regulatory challenges. Journals for international clinical trials must understand these complexities and provide accessible, indexed publication for multi-country research teams. Keith Publications clinical and health journals provide this platform for international clinical trial publication.

Submit Your Manuscript Browse All Topics

What to Look for When Choosing a Journal

Before submitting your research, evaluate journals on these key criteria:

  • International editorial board representing multiple countries and regions
  • No geographic restrictions on author eligibility or manuscript origin
  • Open access model — ensures global readership regardless of institution
  • APC waiver programme for researchers from lower-income countries
  • Multi-currency payment options and institutional billing support
  • English-language support or guidance for non-native English-speaking authors

Recommended Journals — Cluster 3: Health, Medicine & Life Sciences

All journals below are published by Keith Publications — open access, peer-reviewed, and indexed for global discoverability.

  • Health Sciences and Medical Research Journal (HSMRJ)

    Health sciences, clinical medicine, public health, epidemiology, biomedical research, and interdisciplinary studies advancing human health outcomes.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Health Sciences Clinical Medicine Public Health Epidemiology
    Submit Manuscript View Journal
  • Columbia Journal of Medicine and Healthcare (CJMH)

    Medical research, healthcare delivery, hospital management, clinical practice, health policy, and translational medicine bridging research and patient care.

    Review: 2–3 weeks Open Access DOI (CrossRef) Google Scholar
    Medical Research Healthcare Delivery Clinical Practice Health Policy
    Submit Manuscript View Journal
  • Journal of Nursing and Allied Health Sciences (JNAHS)

    Nursing practice, allied health professions, patient care, clinical nursing research, health education, and evidence-based practice across healthcare settings.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Nursing Practice Allied Health Patient Care Health Education
    Submit Manuscript View Journal
  • Journal of Pharmacology and Biomedical Research (JPBR)

    Pharmacology, drug discovery, biomedical sciences, life sciences, oncology, biochemistry, and molecular medicine with clinical and applied relevance.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Pharmacology Drug Research Biomedical Sciences Life Sciences
    Submit Manuscript View Journal

Fast Publication: All Keith Publications journals complete initial review within 2–5 business days and full peer review within 2–4 weeks. Articles are published online within 5–10 days of acceptance — making us one of the fastest open access publishers in the health sciences and medicine field.

Publishing Health Research on the Global Stage

Health challenges are universal — infectious disease, chronic illness, mental health, maternal mortality, cancer, and pharmaceutical access affect communities on every continent. Keith Publications health and medical journals welcome submissions from researchers in every country, from major research universities in the USA and UK to community health researchers in Africa, Asia, and Latin America. Our open access model ensures your research is equally accessible to colleagues in Nairobi, Mumbai, São Paulo, or London — removing the geographic inequalities that have historically disadvantaged researchers from lower-income health systems.

Support for Health Researchers in Developing Countries

Keith Publications is committed to supporting health researchers from developing and emerging economies. We offer APC waiver programmes for eligible researchers, clear and plain-English submission guidelines, and a responsive editorial support team that assists authors navigating the publication process for the first time. Our international editorial board ensures research from diverse global contexts — including health challenges unique to low- and middle-income settings — is evaluated fairly and published alongside research from higher-income research environments. Health innovation and discovery happen everywhere, and we are committed to ensuring it can be shared globally.

Tips to Maximise Your Acceptance Chances

  1. Align your topic with the journal's scope — read the aims and scope carefully before submitting.
  2. Write a compelling abstract — clearly state your research question, methodology, key findings, and clinical or scientific significance.
  3. Ensure ethical compliance — include ethics committee approval, patient consent, and clinical trial registration details where applicable.
  4. Follow reporting guidelines — use CONSORT, STROBE, CARE, PRISMA, or other relevant Equator Network standards for your study design.
  5. Use current and relevant references — cite recent publications alongside seminal works in your health sciences discipline.
  6. Follow formatting guidelines exactly — non-compliant manuscripts are often desk-rejected without peer review.
  7. State practical implications — explain how your health or medical findings can improve patient care or inform health policy.

Frequently Asked Questions

What are the reporting requirements for international multi-site clinical trials?
International multi-site trials require: CONSORT 2010 reporting, registration in an international registry (ClinicalTrials.gov, ISRCTN, or WHO ICTRP) before recruitment begins, ethics approval from all participating countries, ICH E6 GCP compliance documentation, site-by-site enrolment data, and analysis of country/site as a subgroup where sample size permits.
Can Phase II international oncology trials be published at Keith Publications?
Yes. Phase I and II oncology trials — including early-phase dose-finding studies, safety and tolerability assessments, and preliminary efficacy data from international multi-site trials — are within scope for Keith Publications pharmacology and health journals.
How should international trial data from LMICs be presented?
Present LMIC site data transparently, including context-specific factors (baseline health status, standard of care at the site, enrolment challenges). Provide site-stratified results where feasible. Discuss the external validity of trial findings across high- and low-income settings — a critical interpretive dimension for international clinical evidence.
Can trials of traditional medicine interventions conducted across multiple countries be published?
Yes. Multi-country trials of traditional medicine interventions — conducted with CONSORT compliance, appropriate registration, and multi-country ethics approval — are within scope for Keith Publications pharmacology and health journals, representing important evidence on globally-used traditional therapies.

Related Research Guides

Explore other research journal guides in the Health, Medicine & Life Sciences cluster:

Ready to Publish Your Research?

Submit your health sciences, medical, nursing, or life sciences manuscript to Keith Publications today. Fast peer review, open access, and global indexing — get your work published within weeks.

Submit Your Manuscript Now Contact the Editorial Team